Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C.M, Licht, C, Muus, P, Greenbaum, L.A, Babu, S, Bedrosian, C, Bingham, C, Cohen, D.J, Delmas, Y, Douglas, K, Eitner, F, Feldkamp, T, Fouque, D, Furman, R.R, Gaber, O, Herthelius, M, Hourmant, M, Karpman, D, Lebranchu, Y, Mariat, C, Menne, J, Moulin, B, Nürnberger, J, Ogawa, M, Remuzzi, G, Richard, T, Sberro-Soussan, R, Severino, B, Sheerin, N.S, Trivelli, A, Zimmerhackl, L.B, Goodship, T, Loirat, C
Published in The New England journal of medicine (06.06.2013)
Published in The New England journal of medicine (06.06.2013)
Get full text
Journal Article
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry
Schrezenmeier, Hubert, Muus, Petra, Socié, Gérard, Szer, Jeffrey, Urbano-Ispizua, Alvaro, Maciejewski, Jaroslaw P, Brodsky, Robert A, Bessler, Monica, Kanakura, Yuzuru, Rosse, Wendell, Khursigara, Gus, Bedrosian, Camille, Hillmen, Peter
Published in Haematologica (Roma) (01.05.2014)
Published in Haematologica (Roma) (01.05.2014)
Get full text
Journal Article
Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry
Socié, G., Schrezenmeier, H., Muus, P., Lisukov, I., Röth, A., Kulasekararaj, A., Lee, J. W., Araten, D., Hill, A., Brodsky, R., Urbano-Ispizua, A., Szer, J., Wilson, A., Hillmen, P.
Published in Internal medicine journal (01.09.2016)
Published in Internal medicine journal (01.09.2016)
Get full text
Journal Article
Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria
VAN BIJNEN, S. T. A., VAN HEERDE, W. L., MUUS, P.
Published in Journal of thrombosis and haemostasis (01.01.2012)
Published in Journal of thrombosis and haemostasis (01.01.2012)
Get full text
Journal Article
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
Saft, Leonie, Karimi, Mohsen, Ghaderi, Mehran, Matolcsy, András, Mufti, Ghulam J, Kulasekararaj, Austin, Göhring, Gudrun, Giagounidis, Aristoteles, Selleslag, Dominik, Muus, Petra, Sanz, Guillermo, Mittelman, Moshe, Bowen, David, Porwit, Anna, Fu, Tommy, Backstrom, Jay, Fenaux, Pierre, MacBeth, Kyle J, Hellström-Lindberg, Eva
Published in Haematologica (Roma) (01.06.2014)
Published in Haematologica (Roma) (01.06.2014)
Get full text
Journal Article
Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40
RIJNEVELD, A. W, VAN DER HOLT, B, WIJERMANS, P. W, WITTEBOL, S, SPOELSTRA, F. M, DEKKER, A. W, OSSENKOPPELE, G. J, WILLEMZE, R, CORNELISSEN, J. J, DAENEN, Smgj, BIEMOND, B. J, DE WEERDT, O, MUUS, P, MAERTENS, J, MATTIJSSEN, V, DEMUYNCK, H, LEGDEUR, Mcjc
Published in Leukemia (01.11.2011)
Published in Leukemia (01.11.2011)
Get full text
Journal Article
Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab
van Bijnen, S.T.A, Østerud, B, Barteling, W, Verbeek-Knobbe, K, Willemsen, M, van Heerde, W.L, Muus, P
Published in Thrombosis research (01.08.2015)
Published in Thrombosis research (01.08.2015)
Get full text
Journal Article
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial
DE WITTE, Theo, HAGEMEIJER, Anne, AMADORI, Sergio, MUUS, Petra, JANSEN, Joop H, HELLSTRÖM-LINDBERG, Eva, KOVACSOVICS, Tibor, WIJERMANS, Pierre, OSSENKOPPELE, Gert, GRATWOHL, Alois, MARIE, Jean-Pierre, WILLEMZE, Roel, SUCIU, Stefan, BELHABRI, Amin, DELFORGE, Michel, KOBBE, Guido, SELLESLAG, Dominik, SCHOUTEN, Harry C, FERRANT, Augustin, BIERSACK, Harald
Published in Haematologica (Roma) (01.10.2010)
Published in Haematologica (Roma) (01.10.2010)
Get full text
Journal Article
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT
Hengeveld, M, Suciu, S, Chelgoum, Y, Marie, J-P, Muus, P, Lefrère, F, Mandelli, F, Pane, F, Amadori, S, Fioritoni, G, Labar, B, Baron, F, Cermak, J, Bourhis, J-H, Storti, G, Fazi, P, Hagemeijer, A, Vignetti, M, Willemze, R, de Witte, T
Published in Bone marrow transplantation (Basingstoke) (01.03.2015)
Published in Bone marrow transplantation (Basingstoke) (01.03.2015)
Get full text
Journal Article
Web Resource
97 CHARACTERISTICS OF ROMIPLOSTIM-TREATED MDS PATIENTS WITH HEMATOLOGIC IMPROVEMENT IN PLATELETS (HI-P)
Fenaux, P, Muus, P, Kantarjian, H, Lyons, R.M, Larson, R.A, Sekeres, M.A, Becker, P.S, Orejudos, A, Franklin, J
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumab
Otters, E.F.M., Zarafonitis, G., Steenbergen, E.J., van der Valk, P.G.M., Muus, P.
Published in British journal of dermatology (1951) (01.10.2014)
Published in British journal of dermatology (1951) (01.10.2014)
Get full text
Journal Article
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)
Willemze, R., Suciu, S., Muus, P., Halkes, C. J. M., Meloni, G., Meert, L., Karrasch, M., Rapion, J., Vignetti, M., Amadori, S., de Witte, T., Marie, J. P.
Published in Annals of hematology (01.06.2014)
Published in Annals of hematology (01.06.2014)
Get full text
Journal Article
Gemtuzumab ozogamicin (Mylotarg ) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups
AMADORI, S, SUCIU, S, PRUIJT, J, NOBILE, F, CASSIBBA, V, MARIE, J.-P, BEELDENS, F, BAILA, L, VIGNETTI, M, DE WITTE, T, STASI, R, WILLEMZE, R, MANDELLI, F, SELLESLAG, D, DENZLINGER, C, MUUS, P, STAUDER, R, BERNEMAN, Z
Published in Leukemia (01.10.2005)
Published in Leukemia (01.10.2005)
Get full text
Journal Article
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON
DAENEN, S, DER HOLT, B. Van, BREEMS, D. A, DEMUYNCK, H, MAERTENS, J, WIJERMANS, P. W, WITTEBOL, S, DE KLERK, E. W, CORNELISSEN, J. J, DEKKER, A. W, WILLEMZE, R, RIJNEVELD, A. W, BIEMOND, B. J, MUUS, P, DE LOOSDRECHT, Aa Van, SCHOUTEN, H. C, MARWIJK KOOY, M. Van
Published in Leukemia (01.07.2012)
Published in Leukemia (01.07.2012)
Get full text
Journal Article
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
FENAUX, P, CHEVRET, S, BORDESSOULE, D, STOPPA, A.-M, SACLOUN, A, MUUS, P, WANDT, H, MINEUR, P, WHITTAKER, J, FEY, M, DANIEL, M.-T, CASTAIGNE, S, GUERCI, A, DEGOS, L, FEGUEUX, N, DOMBRET, H, THOMAS, X, SANZ, M, LINK, H, MALOISEL, F, GARDIN, C
Published in Leukemia (01.08.2000)
Published in Leukemia (01.08.2000)
Get full text
Journal Article
P-180 Final report of an open-label extension (OLE) study of romiplostim in MDS with a focus on patients with prolonged treatment
Fenaux, P, Kantarjian, H, Muus, P, Lyons, R.M, Larson, R.A, Sekeres, M.A, Becker, P.S, Jia, C, Yang, A.S
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
62 MUTATIONS IN EPIGENETIC REGULATORS ARE SIGNIFICANTLY ASSOCIATED WITH ABERRANT EXPRESSION OF MYELOID DIFFERENTIATION ANTIGENS ON MYELOID PROGENITOR CELLS IN LOW/INTERMEDIATE RISK MDS
Coelho, P. Silva, Cremers, E.M.P, Westers, T.M, de Graaf, A.O, Alhan, C, Cali, C, Visser-Wisselaar, H.A, Chitu, D.A, Vellenga, E, Klein, S.K, Wijermans, P.W, de Greef, G.E, Legdeur, M.C, Muus, P, Ossenkoppele, G.J, Stevens-Kroef, M.J.P.L, van der Reijden, B, Jansen, J.H, van de Loosdrecht, A.A
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
P-277 Decitabine vs. best supportive care in elderly higher-risk MDS patients with or without monosomal karyotypes: EORTC-LG/GMDS-SG phase III trial 06011
Lübbert, M, Suciu, S, Hagemeijer, A, Platzbecker, U, Giagounidis, A, Selleslag, D, Germing, U, Salih, H.R, Muus, P, Bogatyreva, L, Aul, C, De Witte, T, Ganser, A, Huls, G, Marie, J.P, Wijermans, P
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article